Trade Mark Journal No.2025/042 17 October 2025
WO0000001878483 (5)
Office of origin: United States of America
Date of International Registration:5 September 2025
Date of designation in the UK:
5 September 2025

International priority date claimed: 30 April 2025
(United States of America)
(99164118)
- Class 5
- Pharmaceutical formulation for transcutaneous drug delivery for the treatment of skin conditions and wounds.
Christopher Otiko
Representative: Kimberly Bullock Gatling Fox Rothschild LLP, 212 Carnegie Center Drive, Suite 400, Princeton NJ 08540, UNITED STATES OF AMERICA